Digital Exclusion and Inequality in Light of Innovation and Service Transformation Har passerat
Onsdag 15 maj 2024 11:00 - 11:30 F2
Föreläsare: Dimitri Varsamis
Spår: Framväxande teknologier
The roll-out of digital innovation across all tiers of healthcare provision can inherently result in some patients finding it harder or indeed impossible to use new digital models of accessing care. Over 2022, the national-level digital health policy-makers in England facilitated the local take-up and implementation of patient-facing digital innovations for key clinical areas through a dedicated Fund. Alongside this, funding was made available to undertake exploratory work to help the local decision-makers understand how their populations are affected by digital exclusion.
You will hear about the findings from the Digital Inclusion and Health Inequality projects from local integrated care systems and providers, in overcoming barriers to creating digitally equitable pathways. Find out what tools, knowledge and guidance is needed to achieve Inclusive Digital Transformation across clinical pathways.
Seminarietyp
Förinspelat + På plats
Föreläsningsformat
Presentation
Föreläsningssyfte
Orientering
Målgrupp
Chef/Beslutsfattare
Verksamhetsutveckling
Vårdpersonal
Nyckelord
Exempel från verkligheten (goda/dåliga)
Konferens
Vitalis
Föreläsare
Dimitri Varsamis Föreläsare
Healthcare Director - EMEA
UiPath
Dimitri Varsamis PhD is the EMEA Healthcare Director for NYSE-listed UiPath, the AI and automation company.
In his last UK NHS role as NHS England’s Head of Digital Innovation Delivery, he focused on patient-facing hospital solutions. Previously, as Senior Policy Lead for Digital Primary Care, he oversaw the national General Practice contract and financing in rolling out new digital services through all 6,500 GP practices. He had previously worked on national clinical policy and local service redesign in hospitals and purchasing.
Internationally, he represented the UK on the EU Joint Action on Chronic Diseases; researched digital primary care in USA, Australia and New Zealand as a Churchill Fellow; served at the UK Government Department for International Trade.
He has a medical engineering degree from the University of Kent, an MSc in medical diagnostics and a PhD in biosensor development, both from Cranfield University.